(CSCO) Cisco Systems - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US17275R1023
Stock: Networking, Security, Collaboration, Software, Hardware
Total Rating 62
Risk 73
Buy Signal -0.05
| Risk 5d forecast | |
|---|---|
| Volatility | 23.1% |
| Relative Tail Risk | -13.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.86 |
| Alpha | 10.48 |
| Character TTM | |
|---|---|
| Beta | 0.904 |
| Beta Downside | 0.943 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.16% |
| CAGR/Max DD | 1.04 |
EPS (Earnings per Share)
Revenue
Description: CSCO Cisco Systems March 05, 2026
Cisco Systems, Inc. develops and sells internet-related technologies globally. The companys offerings include data center switching, network security, and collaboration tools like Webex. Its business model involves selling hardware, software, and services through direct sales and channel partners.
Cisco operates in the Communications Equipment sector, a segment of the broader technology industry that provides infrastructure for digital communication. This sector is characterized by rapid technological advancements and a shift towards subscription-based software and services.
Cisco also provides network assurance, monitoring, and analytics solutions, alongside professional and technical support services. The company serves a diverse client base including businesses, governments, and service providers. For more detailed financial analysis, consider exploring ValueRay.
Headlines to watch out for
- Enterprise network hardware demand impacts revenue
- Cybersecurity solutions growth drives software sales
- Cloud transition services adoption boosts recurring revenue
- Global IT spending trends influence product sales
- Supply chain disruptions affect hardware delivery and costs
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 11.08b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.14 > 1.0 |
| NWC/Revenue: -2.80% < 20% (prev -9.85%; Δ 7.05% < -1%) |
| CFO/TA 0.11 > 3% & CFO 13.32b > Net Income 11.08b |
| Net Debt (22.63b) to EBITDA (17.00b): 1.33 < 3 |
| Current Ratio: 0.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.99b) vs 12m ago -0.45% < -2% |
| Gross Margin: 64.81% > 18% (prev 0.65%; Δ 6416 % > 0.5%) |
| Asset Turnover: 48.26% > 50% (prev 44.64%; Δ 3.62% > 0%) |
| Interest Coverage Ratio: 9.71 > 6 (EBITDA TTM 17.00b / Interest Expense TTM 1.49b) |
Altman Z'' 1.37
| A: -0.01 (Total Current Assets 35.13b - Total Current Liabilities 36.79b) / Total Assets 123.37b |
| B: 0.00 (Retained Earnings 66.0m / Total Assets 123.37b) |
| C: 0.12 (EBIT TTM 14.47b / Avg Total Assets 122.37b) |
| D: 0.63 (Book Value of Equity 47.72b / Total Liabilities 75.65b) |
| Altman-Z'' Score: 1.37 = BB |
Beneish M -2.98
| DSRI: 1.00 (Receivables 9.55b/8.74b, Revenue 59.05b/54.18b) |
| GMI: 1.00 (GM 64.81% / 65.13%) |
| AQI: 1.00 (AQ_t 0.70 / AQ_t-1 0.70) |
| SGI: 1.09 (Revenue 59.05b / 54.18b) |
| TATA: -0.02 (NI 11.08b - CFO 13.32b) / TA 123.37b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of CSCO shares?
As of March 09, 2026, the stock is trading at USD 78.64 with a total of 20,434,249 shares traded.
Over the past week, the price has changed by -0.98%, over one month by -9.38%, over three months by +0.25% and over the past year by +29.79%.
Over the past week, the price has changed by -0.98%, over one month by -9.38%, over three months by +0.25% and over the past year by +29.79%.
Is CSCO a buy, sell or hold?
Cisco Systems has received a consensus analysts rating of 3.92.
Therefore, it is recommended to buy CSCO.
- StrongBuy: 10
- Buy: 5
- Hold: 10
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CSCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 88.8 | 12.9% |
| Analysts Target Price | 88.8 | 12.9% |
CSCO Fundamental Data Overview March 07, 2026
P/E Trailing = 28.2878
P/E Forward = 19.1939
P/S = 5.2615
P/B = 6.6222
P/EG = 1.3717
Revenue TTM = 59.05b USD
EBIT TTM = 14.47b USD
EBITDA TTM = 17.00b USD
Long Term Debt = 21.37b USD (from longTermDebt, last quarter)
Short Term Debt = 8.72b USD (from shortTermDebt, last quarter)
Debt = 30.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 22.63b USD (from netDebt column, last quarter)
Enterprise Value = 333.34b USD (310.71b + Debt 30.09b - CCE 7.46b)
Interest Coverage Ratio = 9.71 (Ebit TTM 14.47b / Interest Expense TTM 1.49b)
EV/FCF = 25.95x (Enterprise Value 333.34b / FCF TTM 12.85b)
FCF Yield = 3.85% (FCF TTM 12.85b / Enterprise Value 333.34b)
FCF Margin = 21.75% (FCF TTM 12.85b / Revenue TTM 59.05b)
Net Margin = 18.76% (Net Income TTM 11.08b / Revenue TTM 59.05b)
Gross Margin = 64.81% ((Revenue TTM 59.05b - Cost of Revenue TTM 20.78b) / Revenue TTM)
Gross Margin QoQ = 64.97% (prev 65.48%)
Tobins Q-Ratio = 2.70 (Enterprise Value 333.34b / Total Assets 123.37b)
Interest Expense / Debt = 1.23% (Interest Expense 370.0m / Debt 30.09b)
Taxrate = 12.92% (471.0m / 3.65b)
NOPAT = 12.60b (EBIT 14.47b * (1 - 12.92%))
Current Ratio = 0.96 (Total Current Assets 35.13b / Total Current Liabilities 36.79b)
Debt / Equity = 0.63 (Debt 30.09b / totalStockholderEquity, last quarter 47.72b)
Debt / EBITDA = 1.33 (Net Debt 22.63b / EBITDA 17.00b)
Debt / FCF = 1.76 (Net Debt 22.63b / FCF TTM 12.85b)
Total Stockholder Equity = 46.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.05% (Net Income 11.08b / Total Assets 123.37b)
RoE = 23.64% (Net Income TTM 11.08b / Total Stockholder Equity 46.84b)
RoCE = 21.22% (EBIT 14.47b / Capital Employed (Equity 46.84b + L.T.Debt 21.37b))
RoIC = 16.64% (NOPAT 12.60b / Invested Capital 75.73b)
WACC = 8.52% (E(310.71b)/V(340.80b) * Re(9.24%) + D(30.09b)/V(340.80b) * Rd(1.23%) * (1-Tc(0.13)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.32%
[DCF] Terminal Value 76.51% ; FCFF base≈12.83b ; Y1≈13.08b ; Y5≈14.38b
[DCF] Fair Price = 52.19 (EV 228.78b - Net Debt 22.63b = Equity 206.15b / Shares 3.95b; r=8.52% [WACC]; 5y FCF grow 1.72% → 2.90% )
EPS Correlation: 37.77 | EPS CAGR: 4.87% | SUE: 1.29 | # QB: 2
Revenue Correlation: 51.54 | Revenue CAGR: 4.89% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-04-30): EPS=1.03 | Chg7d=+0.004 | Chg30d=+0.004 | Revisions Net=+3 | Analysts=20
EPS current Year (2026-07-31): EPS=4.16 | Chg7d=+0.031 | Chg30d=+0.035 | Revisions Net=+16 | Growth EPS=+9.1% | Growth Revenue=+8.7%
EPS next Year (2027-07-31): EPS=4.52 | Chg7d=+0.038 | Chg30d=+0.043 | Revisions Net=+15 | Growth EPS=+8.6% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: +0.18 (10 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.7% (Discount Rate 9.2% - Earnings Yield 3.5%)
[Growth] Growth Spread = +4.1% (Analyst 9.8% - Implied 5.7%)
P/E Forward = 19.1939
P/S = 5.2615
P/B = 6.6222
P/EG = 1.3717
Revenue TTM = 59.05b USD
EBIT TTM = 14.47b USD
EBITDA TTM = 17.00b USD
Long Term Debt = 21.37b USD (from longTermDebt, last quarter)
Short Term Debt = 8.72b USD (from shortTermDebt, last quarter)
Debt = 30.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 22.63b USD (from netDebt column, last quarter)
Enterprise Value = 333.34b USD (310.71b + Debt 30.09b - CCE 7.46b)
Interest Coverage Ratio = 9.71 (Ebit TTM 14.47b / Interest Expense TTM 1.49b)
EV/FCF = 25.95x (Enterprise Value 333.34b / FCF TTM 12.85b)
FCF Yield = 3.85% (FCF TTM 12.85b / Enterprise Value 333.34b)
FCF Margin = 21.75% (FCF TTM 12.85b / Revenue TTM 59.05b)
Net Margin = 18.76% (Net Income TTM 11.08b / Revenue TTM 59.05b)
Gross Margin = 64.81% ((Revenue TTM 59.05b - Cost of Revenue TTM 20.78b) / Revenue TTM)
Gross Margin QoQ = 64.97% (prev 65.48%)
Tobins Q-Ratio = 2.70 (Enterprise Value 333.34b / Total Assets 123.37b)
Interest Expense / Debt = 1.23% (Interest Expense 370.0m / Debt 30.09b)
Taxrate = 12.92% (471.0m / 3.65b)
NOPAT = 12.60b (EBIT 14.47b * (1 - 12.92%))
Current Ratio = 0.96 (Total Current Assets 35.13b / Total Current Liabilities 36.79b)
Debt / Equity = 0.63 (Debt 30.09b / totalStockholderEquity, last quarter 47.72b)
Debt / EBITDA = 1.33 (Net Debt 22.63b / EBITDA 17.00b)
Debt / FCF = 1.76 (Net Debt 22.63b / FCF TTM 12.85b)
Total Stockholder Equity = 46.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.05% (Net Income 11.08b / Total Assets 123.37b)
RoE = 23.64% (Net Income TTM 11.08b / Total Stockholder Equity 46.84b)
RoCE = 21.22% (EBIT 14.47b / Capital Employed (Equity 46.84b + L.T.Debt 21.37b))
RoIC = 16.64% (NOPAT 12.60b / Invested Capital 75.73b)
WACC = 8.52% (E(310.71b)/V(340.80b) * Re(9.24%) + D(30.09b)/V(340.80b) * Rd(1.23%) * (1-Tc(0.13)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.32%
[DCF] Terminal Value 76.51% ; FCFF base≈12.83b ; Y1≈13.08b ; Y5≈14.38b
[DCF] Fair Price = 52.19 (EV 228.78b - Net Debt 22.63b = Equity 206.15b / Shares 3.95b; r=8.52% [WACC]; 5y FCF grow 1.72% → 2.90% )
EPS Correlation: 37.77 | EPS CAGR: 4.87% | SUE: 1.29 | # QB: 2
Revenue Correlation: 51.54 | Revenue CAGR: 4.89% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-04-30): EPS=1.03 | Chg7d=+0.004 | Chg30d=+0.004 | Revisions Net=+3 | Analysts=20
EPS current Year (2026-07-31): EPS=4.16 | Chg7d=+0.031 | Chg30d=+0.035 | Revisions Net=+16 | Growth EPS=+9.1% | Growth Revenue=+8.7%
EPS next Year (2027-07-31): EPS=4.52 | Chg7d=+0.038 | Chg30d=+0.043 | Revisions Net=+15 | Growth EPS=+8.6% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: +0.18 (10 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.7% (Discount Rate 9.2% - Earnings Yield 3.5%)
[Growth] Growth Spread = +4.1% (Analyst 9.8% - Implied 5.7%)